|
[Related PubMed/MEDLINE]
Total Number of Papers: 117
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: OLGs |
| Long Form |
: oligodendrocytes |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2021 |
SIRT1 decelerates morphological processing of oligodendrocyte cell lines and regulates the expression of cytoskeleton-related oligodendrocyte proteins. |
TPPP |
| 2 |
2021 |
The Role of the lncRNA-LRCF in Propofol-Induced Oligodendrocyte Damage in Neonatal Mouse. |
lncRNA, miRNA, TFBS |
| 3 |
2020 |
Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in Oligodendrocytes. |
MS, OPCs, PI3K, PKC |
| 4 |
2020 |
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions. |
GCIs, MSA |
| 5 |
2020 |
Lithium treatment mitigates white matter injury after intracerebral hemorrhage through brain-derived neurotrophic factor signaling in mice. |
BDNF, GSK-3beta, ICH, WMI |
| 6 |
2020 |
Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. |
CPZ, MET, MS, mTOR |
| 7 |
2020 |
Sodium-Calcium Exchangers of the SLC8 Family in Oligodendrocytes: Functional Properties in Health and Disease. |
SLC8 |
| 8 |
2019 |
Chronic exposure to high fat diet triggers myelin disruption and interleukin-33 upregulation in hypothalamus. |
CNS, HFD, IL-33 |
| 9 |
2019 |
Down-regulation of interleukin-33 expression in oligodendrocyte precursor cells impairs oligodendrocyte lineage progression. |
IL-33, IL33-KO, MBP, PLP, TEM, WT |
| 10 |
2019 |
Effects of the CRMP2 activator lanthionine ketimine ethyl ester on oligodendrocyte progenitor cells. |
CRMP2, LKE, OPCs |
| 11 |
2019 |
Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy. |
EAE, MAT, MS |
| 12 |
2019 |
Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study. |
cup, Klf, MZFs, SPs, TFAPs, ZNFPs |
| 13 |
2018 |
Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions. |
ApoD, MS |
| 14 |
2018 |
Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-kappaB activation and acceleration of intrinsic myelin repair. |
Cup, MS, NF-kappaB, TP |
| 15 |
2018 |
Pathological Endogenous alpha-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy. |
GCIs, OPCs, PFFs |
| 16 |
2017 |
Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation. |
ALA, CC, CNS, cup, MS, ROSs |
| 17 |
2017 |
Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair. |
EAE, MS, NSCs |
| 18 |
2017 |
MicroRNA-212 inhibits oligodendrocytes during maturation by down-regulation of differentiation-associated gene expression. |
CNPase, GC, GPCs, MBP, mir-212, OPCs, PLP1 |
| 19 |
2017 |
Neurons define non-myelinated axon segments by the regulation of galectin-4-containing axon membrane domains. |
G4Ds, Gal-4 |
| 20 |
2017 |
Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis. |
CC, cup, EA, IL-11, IL-17, SDF-1alpha |
| 21 |
2017 |
Protecting Oligodendrocytes by Targeting Non-Glutamate Receptors as a New Therapeutic Strategy for Ischemic Stroke. |
--- |
| 22 |
2017 |
Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential. |
PD |
| 23 |
2016 |
A novel function of TBK1 as a target of Cdon in oligodendrocyte differentiation and myelination. |
Cdon, IP, TBK1 |
| 24 |
2016 |
Extracellular cues influencing oligodendrocyte differentiation and (re)myelination. |
ECM |
| 25 |
2016 |
HIV-1 Tat Inhibits Autotaxin Lysophospholipase D Activity and Modulates Oligodendrocyte Differentiation. |
ATX, LPA, LPC, lysoPLD |
| 26 |
2016 |
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains. |
--- |
| 27 |
2016 |
Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation. |
CNS, MAG, MBP, OLPs, Shh, Smo |
| 28 |
2015 |
Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases. |
CNS, EGFP, PLP, Tg, TM |
| 29 |
2015 |
Pio del Rio Hortega and the discovery of the oligodendrocytes. |
CNS |
| 30 |
2015 |
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation. |
ATX, LPA, lysoPLD |
| 31 |
2015 |
Transferrin and thyroid hormone converge in the control of myelinogenesis. |
aTf, NSCs, OPCs, TH |
| 32 |
2014 |
Concepts for regulation of axon integrity by enwrapping glia. |
EG, PNS and CNS, SCs |
| 33 |
2014 |
Histone deacetylase expression in white matter oligodendrocytes after stroke. |
APC, HDACs, OPCs |
| 34 |
2014 |
Interaction of myelin basic protein with cytoskeletal and signaling proteins in cultured primary oligodendrocytes and N19 oligodendroglial cells. |
MBP, ZO-1 |
| 35 |
2013 |
FMRP and myelin protein expression in oligodendrocytes. |
FMRP, FXS, MBP |
| 36 |
2013 |
Gestational nicotine exposure modifies myelin gene expression in the brains of adolescent rats with sex differences. |
CNS, GN, PFC, qRT-PCR |
| 37 |
2013 |
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors. |
OPCs |
| 38 |
2012 |
Classic 18.5- and 21.5-kDa myelin basic protein isoforms associate with cytoskeletal and SH3-domain proteins in the immortalized N19-oligodendroglial cell line stimulated by phorbol ester and IGF-1. |
MBP, ZO-1 |
| 39 |
2012 |
Galectin-4, a novel neuronal regulator of myelination. |
ECM |
| 40 |
2012 |
The 21.5-kDa isoform of myelin basic protein has a non-traditional PY-nuclear-localization signal. |
MBP, RFP |
| 41 |
2012 |
[Molecular mechanism and new protective strategy for ischemic white matter damages]. |
BCCAL, CREB, OPCs, WMLs |
| 42 |
2011 |
C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation. |
--- |
| 43 |
2011 |
Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. |
cupr, S1P |
| 44 |
2011 |
Oligogenesis and oligodendrocyte progenitor maturation vary in different brain regions and partially correlate with local angiogenesis after ischemic stroke. |
BG, CC, CTX, OPCs, tMCAO |
| 45 |
2011 |
Protective effects of catalpol on oligodendrocyte death and myelin breakdown in a rat model of chronic cerebral hypoperfusion. |
CREB, OLG, pCREB, WMLs |
| 46 |
2011 |
Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination. |
CNS, OPCs |
| 47 |
2010 |
CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis. |
CNS, LIF, LVs, MS |
| 48 |
2010 |
Experimental models for analysis of oligodendrocyte pathophysiology in stroke. |
OPCs |
| 49 |
2010 |
Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner. |
EPO, GR, HIF-1alpha, MP, SCI |
| 50 |
2010 |
Simvastatin interferes with process outgrowth and branching of oligodendrocytes. |
CNP, MS |
| 51 |
2010 |
The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy. |
CSM |
| 52 |
2009 |
Ethanol alters the expressions of c-Fos and myelin basic protein in differentiating oligodendrocytes. |
BIM, DoD, MBP, PKC |
| 53 |
2009 |
Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival. |
EAE, MS |
| 54 |
2009 |
Oligovascular signaling in white matter stroke. |
OPCs |
| 55 |
2009 |
Sexual dimorphism in the white matter of rodents. |
--- |
| 56 |
2008 |
Brain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway. |
BF, MAPK, OPCs, PI3K, PLCgamma |
| 57 |
2008 |
Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod. |
S1P |
| 58 |
2008 |
Sexual dimorphism of oligodendrocytes is mediated by differential regulation of signaling pathways. |
DHT, MS |
| 59 |
2007 |
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. |
OPCs, PDGF, S1P |
| 60 |
2007 |
Sorting signals and regulation of cognate basolateral trafficking in myelin biogenesis. |
--- |
| 61 |
2007 |
The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. |
MS, NT-3 |
| 62 |
2006 |
Characterization of thromboxane A2 receptor signaling in developing rat oligodendrocytes: nuclear receptor localization and stimulation of myelin basic protein expression. |
MBP, OPCs |
| 63 |
2006 |
Implications of protease M/neurosin in myelination during experimental demyelination and remyelination. |
CNS, MBP, TNF-alpha |
| 64 |
2006 |
Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes. |
BDNF, BF, MAG, MAPK, MBP, PI3K, PLCgamma, PLP |
| 65 |
2006 |
Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement. |
EAE, MS |
| 66 |
2006 |
Simvastatin regulates oligodendroglial process dynamics and survival. |
MS, OPCs |
| 67 |
2005 |
Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes. |
3-OMS, AD, ASMase, iNOS, NF-kappaB, nSMase, TNF-alpha |
| 68 |
2005 |
Analyses of proteolipid protein mutants show levels of proteolipid protein regulate oligodendrocyte number and cell death in vitro and in vivo. |
jp, PLP |
| 69 |
2005 |
Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease. |
CNS, EAE, MS, NO |
| 70 |
2005 |
Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies. |
FTDP-17, Tg |
| 71 |
2005 |
Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes. |
BDNF, BF, MBP, NGF, NT-3 |
| 72 |
2005 |
Targeted expression of anti-apoptotic protein p35 in oligodendrocytes reduces delayed demyelination and functional impairment after spinal cord injury. |
SCI |
| 73 |
2005 |
Thromboxane A receptor-mediated cell proliferation, survival and gene expression in oligodendrocytes. |
MAPK, OPCs, PKA, PKC |
| 74 |
2004 |
Comparison of in vivo and in vitro subcellular localization of estrogen receptors alpha and beta in oligodendrocytes. |
ERs |
| 75 |
2004 |
Distinctive properties of human adult brain-derived myelin progenitor cells. |
--- |
| 76 |
2004 |
New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents. |
HI |
| 77 |
2004 |
NOVOcan: a molecular link among selected glial cells. |
--- |
| 78 |
2003 |
Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. |
CNS, EAE, MS |
| 79 |
2003 |
Oligodendrocytes express functional A1 adenosine receptors that stimulate cellular migration. |
A1ARs, CPA, NECA, OPCs |
| 80 |
2003 |
The trophic role of oligodendrocytes in the basal forebrain. |
BDNF, BF, NT-3 |
| 81 |
2003 |
Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain. |
OPCs |
| 82 |
2002 |
Analysis of the K+ current profile of mature rat oligodendrocytes in situ. |
--- |
| 83 |
2002 |
Protein kinase C inhibitors counteract the ethanol effects on myelin basic protein expression in differentiating CG-4 oligodendrocytes. |
MBP, PKC, PMA |
| 84 |
2002 |
Regulation and differential expression of tau mRNA isoforms as oligodendrocytes mature in vivo: implications for myelination. |
--- |
| 85 |
2001 |
Amyloid-beta peptides are cytotoxic to oligodendrocytes. |
AD |
| 86 |
2001 |
Ethanol exerts different effects on myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase expression in differentiating CG-4 oligodendrocytes. |
CNP, EtOH, MBP |
| 87 |
2001 |
Phosphorylation of cyclic adenosine monophosphate response element binding protein in oligodendrocytes in the corpus callosum after focal cerebral ischemia in the rat. |
AMP, LCBF, MAG, MBP, MCA, MCAO |
| 88 |
2000 |
Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. |
--- |
| 89 |
2000 |
Effects of transient ethanol exposure on the incorporation of [(3)H]ethanolamine into plasmalogen in the differentiating CG-4 oligodendrocyte cell line. |
diacyl-EPG, EPl, EtOH |
| 90 |
2000 |
In vitro analysis of cell death of spinal oligodendrocytes in a rat model of HTLV-I infection. |
HAM, HTLV-I, TNF-alpha, WKAH |
| 91 |
2000 |
Neuregulins and erbB receptor expression in adult human oligodendrocytes. |
NRGs |
| 92 |
2000 |
Role of caspase-1 subfamily in cytotoxic cytokine-induced oligodendrocyte cell death. |
ICE, MS, TNF |
| 93 |
1999 |
Different neuroligands and signal transduction pathways stimulate CREB phosphorylation at specific developmental stages along oligodendrocyte differentiation. |
--- |
| 94 |
1999 |
Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes. |
Cer, ERK2, MAPKs, Sph, SPP |
| 95 |
1999 |
[Oligodendrocyte cell death by caspase family proteases]. |
MS, TNF |
| 96 |
1998 |
Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes. |
Cer, IKir |
| 97 |
1997 |
Arachidonic acid inhibits myelin basic protein phosphorylation in cultured oligodendrocytes. |
AA, MBP |
| 98 |
1997 |
Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. |
OP |
| 99 |
1997 |
ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. |
MS, TNF |
| 100 |
1997 |
Role of extracellular signal-regulated protein kinases 1 and 2 in oligodendroglial process extension. |
ERK, MBP, MEK, PKC, PMA |
|
A Search Service for Abbreviation / Long Form
